<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01692119</url>
  </required_header>
  <id_info>
    <org_study_id>PHARM-CHF</org_study_id>
    <nct_id>NCT01692119</nct_id>
  </id_info>
  <brief_title>Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure</brief_title>
  <acronym>PHARM-CHF</acronym>
  <official_title>Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure (PHARM-CHF): A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal Union of German Associations of Pharmacists</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universität des Saarlandes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal Union of German Associations of Pharmacists</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate whether a continuous interdisciplinary intervention&#xD;
      improves medication adherence (primary efficacy endpoint) and leads to a reduction of&#xD;
      hospitalizations and mortality (primary safety endpoint) in elderly patients with chronic&#xD;
      heart failure. The intervention, consisting of regular contacts with the local pharmacy and&#xD;
      weekly dosing aids, aims to improve medication adherence and management.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2012</start_date>
  <completion_date type="Actual">March 2019</completion_date>
  <primary_completion_date type="Actual">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of days covered (PDC) by prescribed medication and according to claims data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Days Lost Due to Unplanned Cardiovascular Hospitalizations or Death of Any Cause</measure>
    <time_frame>12 months</time_frame>
    <description>Days lost due to unplanned cardiovascular hospitalizations or death of any cause</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">258</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>regular, pharmacy-based intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>providing medication in weekly dosing aids and regular contacts with the local pharmacy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Regular, pharmacy based intervention</intervention_name>
    <description>Regular, pharmacy-based intervention conducted in cooperation with the treating physician:&#xD;
Medication review at baseline: recording of all medicines currently taken (prescribed medication and self-medication), check for drug-related problems, consolidation of a medication plan.&#xD;
Regularly (weekly): dose-dispensing of the medication (weekly dosing aid), discussion and counseling regarding medication, adherence, potential side effects, and signs and symptoms of cardiac decompensation; blood pressure and pulse measurement. If required: contact with patients' physician.</description>
    <arm_group_label>regular, pharmacy-based intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 60 years and older&#xD;
&#xD;
          -  Chronic heart failure (CHF)&#xD;
&#xD;
          -  Stable CHF medication including a diuretic&#xD;
&#xD;
          -  Hospitalization for decompensated heart failure within past 12 months OR a value of ≥&#xD;
             350 pg/mL for BNP or ≥ 1,400 pg/mL for NT-proBNP&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of a weekly dosing aid&#xD;
&#xD;
          -  Unwillingness or inability to visit a participating pharmacy once a week&#xD;
&#xD;
          -  Planned cardiac surgery&#xD;
&#xD;
          -  Life-expectancy &lt; 6 months&#xD;
&#xD;
          -  Unwillingness or inability to comply with the study protocol (including drug abuse or&#xD;
             alcohol dependency)&#xD;
&#xD;
          -  Participation in other studies (currently or in the last 4 weeks)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Schulz, Prof. PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal Union of German Associations of Pharmacists</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulrich Laufs, Prof. MD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitätsklinikum Leipzig</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saarland University</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.pharm-chf.de</url>
    <description>PHARM-CHF study home page</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 17, 2012</study_first_submitted>
  <study_first_submitted_qc>September 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2012</study_first_posted>
  <results_first_submitted>March 2, 2021</results_first_submitted>
  <results_first_submitted_qc>March 2, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 26, 2021</results_first_posted>
  <last_update_submitted>March 25, 2021</last_update_submitted>
  <last_update_submitted_qc>March 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic heart failure</keyword>
  <keyword>medication adherence</keyword>
  <keyword>pharmacy</keyword>
  <keyword>interdisciplinary care</keyword>
  <keyword>randomized controlled trial</keyword>
  <keyword>mortality</keyword>
  <keyword>hospitalization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 10, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT01692119/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 17, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT01692119/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Regular, Pharmacy-based Intervention</title>
          <description>providing medication in weekly dosing aids and regular contacts with the local pharmacy&#xD;
Regular, pharmacy based intervention: Regular, pharmacy-based intervention conducted in cooperation with the treating physician:&#xD;
Medication review at baseline: recording of all medicines currently taken (prescribed medication and self-medication), check for drug-related problems, consolidation of a medication plan.&#xD;
Regularly (weekly): dose-dispensing of the medication (weekly dosing aid), discussion and counseling regarding medication, adherence, potential side effects, and signs and symptoms of cardiac decompensation; blood pressure and pulse measurement. If required: contact with patients' physician.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>usual care; no medication review, no dose dispensing; study pharmacists unaware of patients in this group.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="130"/>
                <participants group_id="P2" count="128"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="110"/>
                <participants group_id="P2" count="127"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Intervention: pts. did not present to participating pharmacy</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Regular, Pharmacy-based Intervention</title>
          <description>providing medication in weekly dosing aids and regular contacts with the local pharmacy&#xD;
Regular, pharmacy based intervention: Regular, pharmacy-based intervention conducted in cooperation with the treating physician:&#xD;
Medication review at baseline: recording of all medicines currently taken (prescribed medication and self-medication), check for drug-related problems, consolidation of a medication plan.&#xD;
Regularly (weekly): dose-dispensing of the medication (weekly dosing aid), discussion and counseling regarding medication, adherence, potential side effects, and signs and symptoms of cardiac decompensation; blood pressure and pulse measurement. If required: contact with patients' physician.</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>usual care; no medication review, no dose dispensing; study pharmacists unaware of patients in this group.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="110"/>
            <count group_id="B2" value="127"/>
            <count group_id="B3" value="237"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="110"/>
                    <count group_id="B2" value="127"/>
                    <count group_id="B3" value="237"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.1" spread="6.8"/>
                    <measurement group_id="B2" value="74.1" spread="7.2"/>
                    <measurement group_id="B3" value="74.1" spread="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="110"/>
                    <count group_id="B2" value="127"/>
                    <count group_id="B3" value="237"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="91"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="78"/>
                    <measurement group_id="B3" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Medication Adherence</title>
        <description>Percentage of days covered (PDC) by prescribed medication and according to claims data</description>
        <time_frame>12 months</time_frame>
        <population>Patients for whom we were able to calculate a PDC.</population>
        <group_list>
          <group group_id="O1">
            <title>Regular, Pharmacy-based Intervention</title>
            <description>providing medication in weekly dosing aids and regular contacts with the local pharmacy&#xD;
Regular, pharmacy based intervention: Regular, pharmacy-based intervention conducted in cooperation with the treating physician:&#xD;
Medication review at baseline: recording of all medicines currently taken (prescribed medication and self-medication), check for drug-related problems, consolidation of a medication plan.&#xD;
Regularly (weekly): dose-dispensing of the medication (weekly dosing aid), discussion and counseling regarding medication, adherence, potential side effects, and signs and symptoms of cardiac decompensation; blood pressure and pulse measurement. If required: contact with patients' physician.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>usual care; no medication review, no dose dispensing; study pharmacists unaware of patients in this group.</description>
          </group>
        </group_list>
        <measure>
          <title>Medication Adherence</title>
          <description>Percentage of days covered (PDC) by prescribed medication and according to claims data</description>
          <population>Patients for whom we were able to calculate a PDC.</population>
          <units>percentage of days covered</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="112"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.2" spread="11.9"/>
                    <measurement group_id="O2" value="85.5" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Days Lost Due to Unplanned Cardiovascular Hospitalizations or Death of Any Cause</title>
        <description>Days lost due to unplanned cardiovascular hospitalizations or death of any cause</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Regular, Pharmacy-based Intervention</title>
            <description>providing medication in weekly dosing aids and regular contacts with the local pharmacy&#xD;
Regular, pharmacy based intervention: Regular, pharmacy-based intervention conducted in cooperation with the treating physician:&#xD;
Medication review at baseline: recording of all medicines currently taken (prescribed medication and self-medication), check for drug-related problems, consolidation of a medication plan.&#xD;
Regularly (weekly): dose-dispensing of the medication (weekly dosing aid), discussion and counseling regarding medication, adherence, potential side effects, and signs and symptoms of cardiac decompensation; blood pressure and pulse measurement. If required: contact with patients' physician.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>usual care; no medication review, no dose dispensing; study pharmacists unaware of patients in this group.</description>
          </group>
        </group_list>
        <measure>
          <title>Days Lost Due to Unplanned Cardiovascular Hospitalizations or Death of Any Cause</title>
          <description>Days lost due to unplanned cardiovascular hospitalizations or death of any cause</description>
          <units>days lost</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="110"/>
                <count group_id="O2" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.8" lower_limit="10.6" upper_limit="38.9"/>
                    <measurement group_id="O2" value="16.5" lower_limit="6.1" upper_limit="26.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>365 days and until end of the study</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Regular, Pharmacy-based Intervention</title>
          <description>providing medication in weekly dosing aids and regular contacts with the local pharmacy&#xD;
Regular, pharmacy based intervention: Regular, pharmacy-based intervention conducted in cooperation with the treating physician:&#xD;
Medication review at baseline: recording of all medicines currently taken (prescribed medication and self-medication), check for drug-related problems, consolidation of a medication plan.&#xD;
Regularly (weekly): dose-dispensing of the medication (weekly dosing aid), discussion and counseling regarding medication, adherence, potential side effects, and signs and symptoms of cardiac decompensation; blood pressure and pulse measurement. If required: contact with patients' physician.</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>usual care; no medication review, no dose dispensing; study pharmacists unaware of patients in this group.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="110"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="127"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="110"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="127"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="110"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="127"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Martin Schulz</name_or_title>
      <organization>ABDA, Department of Medicine</organization>
      <phone>+49 30 40004-514</phone>
      <email>arzneimittel@abda.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

